China Research-grade Proteins Market Size & Outlook
China research-grade proteins market, 2018-2030 (US$M)
Related Markets
China research-grade proteins market highlights
- The China research-grade proteins market generated a revenue of USD 46.9 million in 2023 and is expected to reach USD 169.6 million by 2030.
- The China market is expected to grow at a CAGR of 20.2% from 2024 to 2030.
- In terms of segment, cytokines & growth factors was the largest revenue generating product in 2023.
- Cytokines & Growth Factors is the most lucrative product segment registering the fastest growth during the forecast period.
Research-grade proteins market data book summary
| Market revenue in 2023 | USD 46.9 million |
| Market revenue in 2030 | USD 169.6 million |
| Growth rate | 20.2% (CAGR from 2023 to 2030) |
| Largest segment | Cytokines & growth factors |
| Fastest growing segment | Cytokines & Growth Factors |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cytokines & Growth Factors, Antibodies, Immune checkpoint proteins, Virus Antigens, Enzymes, Recombinant Regulatory Protein, Hormones |
| Key market players worldwide | Thermo Fisher Scientific Inc, Danaher Corp, Bio-Techne Corp, Sino Biological, Miltenyi Biotec, Proteintech Group, Prospec, New England Biolabs |
Other key industry trends
- In terms of revenue, China accounted for 4.8% of the global research-grade proteins market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China research-grade proteins market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 169.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Research-grade Proteins Market Scope
Research-grade Proteins Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China research-grade proteins market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to research-grade proteins market will help companies and investors design strategic landscapes.
Cytokines & growth factors was the largest segment with a revenue share of 23.45% in 2023. Horizon Databook has segmented the China research-grade proteins market based on cytokines & growth factors, antibodies, immune checkpoint proteins, virus antigens, enzymes, recombinant regulatory protein, hormones covering the revenue growth of each sub-segment from 2018 to 2030.
China is anticipated to witness lucrative growth over the forecast period. This can be attributed to the rising investments in stem cell and cancer research from government & private organizations. These investments help in the development of infrastructure for academic and research institutes by using the latest technologies.
In May 2023, GE HealthCare, a medical equipment company, officially initiated the Precision Medicine Industrial Base project in Chengdu Tianfu International Bio-town.
In July 2023, the European Union (EU) and China collaborated to include China in the International Consortium for Personalized Medicine (IC2PerMed) project to promote personalized medicine.
Reasons to subscribe to China research-grade proteins market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China research-grade proteins market databook
-
Our clientele includes a mix of research-grade proteins market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China research-grade proteins market , including forecasts for subscribers. This country databook contains high-level insights into China research-grade proteins market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China research-grade proteins market size, by product, 2018-2030 (US$M)
China Research-grade Proteins Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
